Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company developing and commercializing tamper-resistant products to combat medication abuse and misuse. The Centers for Disease Control and Prevention estimates that one person dies every 19 minutes from prescription drug abuse in the United States. For over a decade, Acura has been on the forefront of developing solutions to combat this epidemic, with products utilizing the Company’s proprietary abuse deterrent LIMITX™, IMPEDE® and AVERSION® Technologies.
The first two commercial products utilizing Acura’s tamper-resistant technologies are OXAYDO® and NEXAFED®. In addition, Acura has other abuse deterrent products utilizing the LIMITX™ technology in development: Hydromorphone HCl tablets and Hydrocodone bitartrate/acetaminophen tablets.